Publications
349
Citations
14,269
Est. group size
~2
Recurring co-author estimate
Active years
53
Publishing since 1974
This researcher's publication record spans several distinct areas of medicine and health science, including cancer therapy (particularly PARP inhibitors and DNA-repair-deficient tumors), exercise and cardiovascular physiology, and thrombosis-related conditions. The work ranges from laboratory and clinical cancer studies to research on athletic performance testing and the role of kinesiologists (exercise health professionals) in healthcare systems. Note that the bibliographic data appears to combine work from more than one person sharing this name.
Publication activity has gradually declined over the past decade, from roughly 25 per year in 2017 to around 8-11 per year in recent years, averaging about 9.8 annually over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Abstract 6557: Combined PARP inhibition and immune checkpoint blockade elicit differentially improved survival in BRCA1, BRCA2 vs CHEK2, ATM deficient breast cancer by promoting an anti-tumor immune response through tertiary lymphoid structure formation
Cancer Research · 2026
- Potential Regulatory Approaches for Occupant Safety in Automated Vehicles with Unique Seating Configurations – Part 1: Occupant Protection Proposals
SAE technical papers on CD-ROM/SAE technical paper series · 2026
- Potential Regulatory Approaches for Occupant Safety in Automated Vehicles with Unique Seating Configurations – Part 2: Interior Safety Sensing and Messaging Proposals
SAE technical papers on CD-ROM/SAE technical paper series · 2026
- Skeletal muscle oxygenation and fluid content in upper extremity postthrombotic syndrome: a proof-of-concept study
Research and Practice in Thrombosis and Haemostasis · 2025
- Defining Running Intensity Domains from Critical Speed Derived from a 3-Minute All-Out Running Test
Physiologia · 2025
- Perceptions of competencies and education of registered kinesiologists in Ontario
Applied Physiology Nutrition and Metabolism · 2025
- Characterizing safety, toxicity, and breast cancer risk reduction using a long-term fulvestrant eluting implant
Scientific Reports · 2025
- Abstract 5153: Synergistic efficacy of PARP and DNMT inhibition in ATM and CHEK2 CRISP-engineered in vitro and in vivo models
Cancer Research · 2025
- The Effect of Specific Treadmill Protocol on Aerobic Performance Parameters in Flat-Terrain-Trained Athletes
Life · 2025
- A phase I/Ib study of olaparib and ASTX727 in BRCA 1/2- and HRD-mutated tumors.
Journal of Clinical Oncology · 2025
- 533 Geriatric Trauma: Age as a Criterion for Trauma Activation
Annals of Emergency Medicine · 2025
- 484 PARP inhibition augments response to anti-PD1 therapy in HRD mutated breast cancer
Regular and Young Investigator Award Abstracts · 2025
- Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2
JCO Precision Oncology · 2024
- Estimate Anaerobic Work Capacity and Critical Power with Constant-Power All-Out Test
Journal of Functional Morphology and Kinesiology · 2024
- Abstract B019: Deciphering the role of homologous recombination deficiency mutations in the response to combined immune checkpoint and PARP inhibitors
Cancer Research · 2024
- Journal of Clinical Oncology×12
- Journal of Clinical Medicine×9
- Cancer Research×8
- Seminars in Thrombosis and Hemostasis×5
- The Journal of Trauma: Injury, Infection, and Critical Care×4
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile